A61P SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
Introduced: January 2000
Description
A61P classifies chemical compounds and medicinal preparations according to their specific therapeutic effects and clinical applications in human and veterinary medicine. This subclass encompasses pharmaceuticals organized by disease or condition treated, such as agents for cardiovascular, respiratory, gastrointestinal, or neurological disorders, rather than by chemical structure or manufacturing process. Inventions in this category include active pharmaceutical ingredients, drug formulations, and combination therapies where the therapeutic target or indication is the primary classification criterion. Note that this class complements A61K (preparations for medical purposes), which focuses on formulation aspects and composition, whereas A61P emphasizes the therapeutic purpose and biological activity of the preparation.
Additional Content IPC
Drug(s) drugs includes chemical compounds or compositions with therapeutic activity, i.e. having the ability to cause a physiological, pharmacological or biological effect.
IPC and CPC are identically structured here. All 22 subcodes exist in both systems.
3 shared codes have differing titles between IPC and CPC.
IPC defines codes here since 2000.
Child Classifications
Navigate with arrow keys, Enter to open
- A61P 1/00 Drugs for disorders of the alimentary tract or the digestive system since 2000 IPC+CPC Available in IPC and CPC
- A61P 11/00 Drugs for disorders of the respiratory system since 2000 IPC+CPC Available in IPC and CPC
- A61P 15/00 Drugs for genital or sexual disorders (for disorders of sex hormones A61P5/24); Contraceptives since 2000 IPC+CPC Available in IPC and CPC
- A61P 21/00 Drugs for disorders of the muscular or neuromuscular system since 2000 IPC+CPC Available in IPC and CPC
- A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] since 2000 IPC+CPC Available in IPC and CPC
- A61P 3/00 Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00) since 2000 IPC+CPC Available in IPC and CPC
- A61P 31/00 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics since 2000 IPC+CPC Available in IPC and CPC
- A61P 37/00 Drugs for immunological or allergic disorders since 2000 IPC+CPC Available in IPC and CPC
- A61P 41/00 Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution since 2000 IPC+CPC Available in IPC and CPC
- A61P 43/00 Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 since 2000 IPC+CPC Available in IPC and CPC
Top Applicants
Top Applicants (IPC)
Class A61,2013–2023, worldwide · Source: EPO PATSTAT
- PHILIPS ELECTRONICS NL 18,523
- NOVARTIS CH 14,253
- COVIDIEN US 13,953
- ROCHE CH 12,005
- CHINESE ACADEMY OF SCIENCES 11,955
- UNIVERSITY OF CALIFORNIA US 11,692
- HARVARD UNIVERSITY US 11,596
- L'OREAL FR 11,593
- P&G (PROCTER & GAMBLE COMPANY) US 11,297
- OLYMPUS CORPORATION JP 9,594
Top Applicants (CPC)
Class A61,2013–2023, worldwide · Source: EPO PATSTAT
- PHILIPS ELECTRONICS NL 20,621
- NOVARTIS CH 15,792
- ROCHE CH 14,303
- COVIDIEN US 13,862
- HARVARD UNIVERSITY US 13,454
- UNIVERSITY OF CALIFORNIA US 12,798
- P&G (PROCTER & GAMBLE COMPANY) US 12,140
- L'OREAL FR 11,800
- OLYMPUS CORPORATION JP 9,894
- BOSTON SCIENTIFIC SCIMED US 9,513